- SCS, 2021. Breast Cancer. Singapore Cancer Society. Available at: https://www.singaporecancersociety.org.sg/learn-about-cancer/types-of-cancer/breast-cancer.html
- Autier, P. and Boniol, M., 2018. Mammography screening: a major issue in medicine. European Journal of Cancer, 90, pp.34-62.
epiDx®
epiDx® is a blood-based liquid biopsy test for the diagnosis of breast cancer based on the epigenetic differences between breast cancer and healthy individuals.
INEX's Solution
epiDx® is a blood-based liquid biopsy test for the diagnosis of breast cancer based on the epigenetic differences between breast cancer and healthy individuals.
USER-FRIENDLY
Simple blood draw to collect sample for testing.
EARLY DETECTION
Early detection is the key to successful cancer treatment. User-friendly screening process would result in higher screening participation and earlier detection rate of cancer.
ASIAN-FOCUSED
epiDx® is the first-ever test to stratify Asian patients regardless of sub-type and stage of breast cancer with high specificity and sensitivity.
